The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Findings indicate a 12.8% 10-year diabetes risk, driven by fasting plasma glucose, age, sex, and BMI, highlighting the need ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback